Publicaciones en las que colabora con AMAIA AGUIRRE QUIÑONERO (12)

2022

  1. Gonococcal bacteremia: Report of two clinical cases linked with pharyngeal asymptomatic infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 5, pp. 282-283

2021

  1. Haemophilus influenzae type a sequence type 23, Northern Spain

    Emerging Infectious Diseases, Vol. 27, Núm. 9, pp. 2504-2507

  2. High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia: A matter of time?

    Journal of Infection

  3. Molecular epidemiology, antimicrobial surveillance, and pk/pd analysis to guide the treatment of neisseria gonorrhoeae infections

    Pharmaceutics, Vol. 13, Núm. 10

  4. Penicillin susceptibility among invasive MSSA infections: A multicentre study in 16 Spanish hospitals

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2519-2527

  5. Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate compared to linezolid for the treatment of infections caused by gram-positive bacteria

    Antibiotics, Vol. 10, Núm. 7

  6. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  7. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Are oral cefuroxime axetil, cefixime and cefditoren pivoxil adequate to treat uncomplicated acute pyelonephritis after switching from intravenous therapy? A pharmacokinetic/pharmacodynamic perspective

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 7, pp. 306-311

2019

  1. Accuracy of the BD MAX™ vaginal panel in the diagnosis of infectious vaginitis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 5, pp. 877-882

  2. Ciprofloxacin resistance in nontypable Haemophilus influenzae clinical isolates

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 2, pp. 139-140

2018

  1. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men

    European Journal of Clinical Microbiology and Infectious Diseases